Company logo

PAHC - Phibro Animal Health Corporation

NASDAQ -> Healthcare -> Drug Manufacturers—Specialty & Generic
Teaneck, United States
Type: Equity

PAHC price evolution
PAHC
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jul 2023 1 May 2023
Current assets
Cash $32.97 $43.15 $41.28 $37.24
Short term investments $59.52 $48 $40 $40
Net receivables $150.63 $149.23 $163.48 $152.74
Inventory $286.68 $279.15 $277.57 $292.83
Total current assets $586.59 $584.42 $585.72 $585.48
Long term investments
Property, plant & equipment $200.84 $193.36 $195.57 $188.94
Goodwill & intangible assets $105.64 $105.44 $108.26 $110.14
Total noncurrent assets $386.12 $380.1 $385.67 $379.95
Total investments $59.52 $48 $40 $40
Total assets $972.71 $964.52 $971.4 $965.43
Current liabilities
Accounts payable $86.41 $77.22 $73.85 $75.77
Deferred revenue
Short long term debt $26.05 $24.15 $22.3 $15.42
Total current liabilities $187.74 $172.35 $176 $165.31
Long term debt $448.85 $458.72 $452.54 $466.02
Total noncurrent liabilities $514.17 $519.1 $512.89 $527.8
Total debt $474.9 $482.87 $474.84 $481.44
Total liabilities $701.9 $691.45 $688.89 $693.1
Shareholders' equity
Retained earnings $244.45 $248.04 $260.91 $254.28
Other shareholder equity -$109.61 -$110.86 -$114.21 -$117.75
Total shareholder equity $270.8 $273.07 $282.51 $272.33
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Current assets
Cash $41.28 $74.25 $50.21 $36.34
Short term investments $40 $17 $43 $55
Net receivables $163.48 $166.54 $146.85 $126.52
Inventory $277.57 $259.16 $216.31 $196.66
Total current assets $585.72 $566.23 $498.91 $451.84
Long term investments
Property, plant & equipment $195.57 $165.49 $154.71 $148.11
Goodwill & intangible assets $108.26 $117.09 $114.96 $123.68
Total noncurrent assets $385.67 $365.47 $342.42 $332.26
Total investments $40 $17 $43 $55
Total assets $971.4 $931.7 $841.33 $784.1
Current liabilities
Accounts payable $73.85 $95.6 $68.36 $66.09
Deferred revenue
Short long term debt $22.3 $15 $9.38 $18.75
Total current liabilities $176 $190.83 $164.12 $157.24
Long term debt $452.54 $417.93 $382.71 $368.26
Total noncurrent liabilities $512.89 $478.43 $438.68 $438.66
Total debt $474.84 $432.93 $392.08 $387.01
Total liabilities $688.89 $669.26 $602.8 $595.9
Shareholders' equity
Retained earnings $260.91 $247.75 $218.01 $183.06
Other shareholder equity -$114.21 -$121.11 -$115.29 -$130.38
Total shareholder equity $282.51 $262.44 $238.53 $188.2
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 1 May 2023
Revenue
Total revenue $249.94 $231.35 $255.05
Cost of revenue $171.33 $163.62 $178.38
Gross Profit $78.62 $67.73 $76.67
Operating activities
Research & development
Selling, general & administrative $62.91 $68.45 $52.9
Total operating expenses $62.91 $68.45 $52.9
Operating income $15.7 -$0.73 $23.77
Income from continuing operations
EBIT $8.22 -$7.42 $25.94
Income tax expense $2.29 -$3.96 $9.94
Interest expense $4.66 $4.56 $4.5
Net income
Net income $1.27 -$8.02 $11.5
Income (for common shares) $1.27 -$8.02 $11.5
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $977.89 $942.26 $833.35 $800.35
Cost of revenue $679.65 $656.86 $561.97 $543.47
Gross Profit $298.24 $285.4 $271.38 $256.88
Operating activities
Research & development
Selling, general & administrative $226.39 $206.41 $196.51 $187.69
Total operating expenses $226.39 $206.41 $196.51 $187.69
Operating income $71.85 $78.99 $74.87 $69.19
Income from continuing operations
EBIT $69.39 $84.2 $79.35 $68.37
Income tax expense $21.46 $23.15 $12.08 $21.96
Interest expense $15.32 $11.88 $12.88 $12.86
Net income
Net income $32.61 $49.17 $54.38 $33.55
Income (for common shares) $32.61 $49.17 $54.38 $33.55
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $1.27 -$8.02 $11.5 $10.04
Operating activities
Depreciation $8.91 $8.87 $8.57 $8.49
Business acquisitions & disposals -$3.33
Stock-based compensation $0.08 $0.08
Total cash flows from operations $31.56 $16.2 $20.24 $6.26
Investing activities
Capital expenditures -$10.96 -$7.48 -$10.89 -$7.91
Investments -$11.52 -$8 -$30
Total cash flows from investing -$24.86 -$15.35 -$10.28 -$37.78
Financing activities
Dividends paid -$4.86 -$4.86 -$4.86 -$4.86
Sale and purchase of stock
Net borrowings -$9.84 $6.16 -$1.47 $5.14
Total cash flows from financing -$14.71 $1.3 -$6.33 $0.28
Effect of exchange rate -$2.17 -$0.27 $0.42 $0.05
Change in cash and equivalents -$10.18 $1.87 $4.04 -$31.18
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $32.61 $49.17 $54.38 $33.55
Operating activities
Depreciation $34.01 $32.7 $31.89 $32.34
Business acquisitions & disposals -$13.51 -$54.55
Stock-based compensation $1.13 $2.26
Total cash flows from operations $13.31 $31.65 $48.31 $59.35
Investing activities
Capital expenditures -$51.79 -$37.04 -$29.32 -$34.05
Investments -$23 $27.35 $12 -$31
Total cash flows from investing -$74.02 -$22.58 -$18.58 -$120.39
Financing activities
Dividends paid -$19.44 -$19.44 -$19.43 -$19.42
Sale and purchase of stock
Net borrowings $46.43 $40.63 $2.44 $60.35
Total cash flows from financing $26.99 $16.34 -$17 $40.94
Effect of exchange rate $0.75 -$1.37 $1.14 -$1.12
Change in cash and equivalents -$32.97 $24.04 $13.87 -$21.23
Fundamentals
Market cap $528.98M
Enterprise value $970.91M
Shares outstanding 40.50M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 1.39
Book/Share 9.39
Cash/Share 0.81
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 2.44
Net debt/EBITDA N/A
Current ratio 3.12
Quick ratio 1.60